S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10

Terumo Stock Forecast, Price & News

-1.39 (-3.77%)
(As of 01/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
108,718 shs
Average Volume
44,390 shs
Market Capitalization
$26.97 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TRUMY News and Ratings via Email

Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter.

Terumo logo

About Terumo

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.


Short Interest in Terumo Co. (OTCMKTS:TRUMY) Declines By 96.4%
January 27, 2022 |  americanbankingnews.com
JPMorgan Chase & Co. Initiates Coverage on Terumo (OTCMKTS:TRUMY)
January 26, 2022 |  americanbankingnews.com
Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 76.6% in December
January 16, 2022 |  americanbankingnews.com
Terumo Corp. ADR
August 13, 2021 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Medical & hospital equipment
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$5.79 billion
Cash Flow
$1.52 per share
Book Value
$10.60 per share


Net Income
$726.31 million
Pretax Margin




Free Float
Market Cap
$26.97 billion
Not Optionable

Company Calendar

Fiscal Year End

Social Links


Overall MarketRank

1.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Terumo (OTCMKTS:TRUMY) Frequently Asked Questions

Is Terumo a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Terumo stock.
View analyst ratings for Terumo
or view top-rated stocks.

How has Terumo's stock price been impacted by COVID-19?

Terumo's stock was trading at $32.71 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRUMY stock has increased by 8.6% and is now trading at $35.51.
View which stocks have been most impacted by COVID-19

Are investors shorting Terumo?

Terumo saw a drop in short interest in January. As of January 15th, there was short interest totaling 300 shares, a drop of 96.4% from the December 31st total of 8,300 shares. Based on an average trading volume of 32,400 shares, the short-interest ratio is presently 0.0 days.
View Terumo's Short Interest

Is Terumo a good dividend stock?

Terumo pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.54%. The dividend payout ratio of Terumo is 17.70%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Terumo will have a dividend payout ratio of 14.93% next year. This indicates that Terumo will be able to sustain or increase its dividend.

Who are Terumo's key executives?

Terumo's management team includes the following people:
  • Shinjiro Sato, President, CEO & Representative Director
  • Naoki Muto, Chief Financial & Accounting Officer
  • Kazuhisa Senshu, Chief Clinical & Regulatory Affairs Officer
  • Katsuya Takeuchi, Chief Information Officer & Executive Officer
  • Shouji Hatano, Director, Head-Compliance & Legal Affairs

Who are some of Terumo's key competitors?

What is Terumo's stock symbol?

Terumo trades on the OTCMKTS under the ticker symbol "TRUMY."

How do I buy shares of Terumo?

Shares of TRUMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Terumo's stock price today?

One share of TRUMY stock can currently be purchased for approximately $35.51.

How much money does Terumo make?

Terumo has a market capitalization of $26.97 billion and generates $5.79 billion in revenue each year. The company earns $726.31 million in net income (profit) each year or $1.13 on an earnings per share basis.

How many employees does Terumo have?

Terumo employs 26,438 workers across the globe.

When was Terumo founded?

Terumo was founded in 1964.

What is Terumo's official website?

The official website for Terumo is www.terumo.co.jp.

Where are Terumo's headquarters?

How can I contact Terumo?

Terumo's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company can be reached via phone at (133) 374-8111 or via email at [email protected].

This page was last updated on 1/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.